News - Legal, Asia-Pacific


Current filters:


Popular Filters

1 to 25 of 41 results

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP

Roche sues Biocon and Mylan over Herceptin biosimilar; US puts pressure on India over IP


Swiss pharma major Roche’s Indian subsidiary has sued Bangalore-based Biocon and US generics firm Mylan…

Asia-PacificBioconBiosimilarsCanmabHerceptinHertrazIndiaLegalMylan LaboratoriesOncologyPatentsPharmaceuticalRegulationRoche

Sinopharm executives face corruption probe in China


China's largest drug distributor, state-owned Sinopharm, has become the most high profile domestic group…

Asia-PacificChinaLegalMarkets & MarketingPharmaceuticalSinopharm

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade

Japan to investigate Novartis promotion of Diovan; US allegation over Exjade


Swiss drug major Novartis faced two problems yesterday, when the Japanese Ministry of Health Labor and…

Asia-PacificCardio-vascularDiovanExjadeHematologyLegalMarkets & MarketingNorth AmericaNovartisPharmaceuticalUSA

Nissan Chemical and Kowa to sue generic drugmakers over Livalo patent infringements


With the commencement this year of manufacturing and selling generic copies of the hypercholesterolemia…

Asia-PacificCardio-vascularGenericsKowaLegalLivaloNissan ChemicalPatents

New legislation for regenerative medicine in Japan

New legislation for regenerative medicine in Japan


The Japanese legislature (Diet) has approved new legislation targeted at regenerative medicine therapies.…

Asia-PacificBiotechnologyCytori TherapeuticsLegalRegulationResearch

Novartis under investigation for manipulating data in Japanese clinical trials

Novartis under investigation for manipulating data in Japanese clinical trials


Swiss drug major Novartis has said it regrets the inconvenience caused by its investigator-initiated…


Bayer joins string of drugmakers being investigated in China


German pharma and crop sciences major Bayer (BAYN: DE) is being investigated in China over a "potential…

Asia-PacificBayerLegalMarkets & MarketingPharmaceutical

Chinese pharma companies now also implicated in bribery allegations


Chinese drug company Sino Biopharmaceutical is the latest subject of allegations into corruption in the…


GlaxoSmithKline could be considering quitting China, says BBC editor


For most multinational companies, it is a no-brainer that they have to be big in China, if their global…

Asia-PacificGlaxoSmithKlineLegalManagementMarkets & MarketingPharmaceutical

Chinese police reveal more on GSK China's suspected violations


The Chinese police have recently revealed more details about suspected economic violations by UK pharma…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

Eli Lilly latest to become embroiled in China bribery allegations


In the ongoing allegations of bribery and corruption by multinational drugmakers in China, US pharma…

Asia-PacificEli LillyLegalMarkets & MarketingPharmaceutical

China starts investigation of alleged bribery by Sanofi


Following last week's whistleblower allegations that French drug major Sanofi (Euronext: SAN) had paid…

Asia-PacificLegalMarkets & MarketingPharmaceuticalPricingSanofi

Sanofi latest to be implicated Chinese bribery allegations


In the wake of allegations that several multinational pharma companies have engaged in unlawful marketing…

Asia-PacificLegalLundbeckMarkets & MarketingNovo NordiskPharmaceuticalSanofi

Another blow for Pharma, as India revokes Tykerb patent


UK pharma giant GlaxoSmithKline (LSE: GSK) has confirmed that India's Intellectual Property Appellate…


More details emerge of GSK China bribery allegations


The extent of the alleged bribery and tax-related violations by UK pharma major GlaxoSmithKline (LSE:…


Investigation on-going as claims GSK staff may have broken Chinese law


Sales staff at UK pharma major GlaxoSmithKline (LSE: GSK) in China may have broken Chinese law, the company…


China says GSK probe part of business climate clean-up


China's probe into UK pharma major GlaxoSmithKline (LSE: GSK) was part of the country's efforts to improve…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

China probe into GlaxoSmithKline bribery allegations escalates


Investigations in China relating to alleged bribery and tax-related crimes by UK pharma giant GlaxoSmithKline…

Asia-PacificGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

US DoJ says Ranbaxy pleads guilty and agrees to pay $500 million in settlements


In the largest drug safety settlement to date with a generic drug manufacturer, Ranbaxy USA, a subsidiary…

Asia-PacificDaiichi SankyoFinancialGenericsLegalNorth AmericaProductionRanbaxy LaboratoriesRegulation

Japan Supreme Court absolves AstraZeneca over deaths associated with Iressa


The Japanese Supreme Court has upheld high court rulings that the Japanese unit of Anglo-Swedish drug…


India's Supreme Court denies Novartis Glivec patent appeal


In a landmark decision issued on Monday (April 1) by the Indian Supreme Court has denied Swiss drug major…


Cipla prevails in Sutent patent dispute with Pfizer; puts hold on Cipla Medpro deal


The Indian patent office has again ruled in favor of domestic drugmaker Cipla (BSE: 500087), reinstating…

Asia-PacificCiplaCipla MedproGenericsLegalMergers & AcquisitionsOncologyPatentsPfizerRest of the WorldSutent

Novartis Indian patent hearings close, but no verdict yet


After more than 12 weeks of hearings in India's Supreme Court, humanitarian aid agency Medecins Sans…


1 to 25 of 41 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top